160 related articles for article (PubMed ID: 31432428)
1. Bioinformatics to Tackle the Biological Meaning of Human Cerebrospinal Fluid Proteome.
Trindade F; Nogueira-Ferreira R; Bastos P; Amado F; Ferreira R; Vitorino R
Methods Mol Biol; 2019; 2044():393-553. PubMed ID: 31432428
[TBL] [Abstract][Full Text] [Related]
2. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
[TBL] [Abstract][Full Text] [Related]
3. Trait Loci Mapping and CSF Proteome.
Sasayama D; Hattori K; Kunugi H
Methods Mol Biol; 2019; 2044():365-376. PubMed ID: 31432426
[TBL] [Abstract][Full Text] [Related]
4. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
[TBL] [Abstract][Full Text] [Related]
5. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
6. The Human Brain Proteome Project: Biological and Technological Challenges.
Fernández-Irigoyen J; Corrales F; Santamaría E
Methods Mol Biol; 2019; 2044():3-23. PubMed ID: 31432403
[TBL] [Abstract][Full Text] [Related]
7. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
9. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
10. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
11. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
12. How to use and integrate bioinformatics tools to compare proteomic data from distinct conditions? A tutorial using the pathological similarities between Aortic Valve Stenosis and Coronary Artery Disease as a case-study.
Trindade F; Ferreira R; Magalhães B; Leite-Moreira A; Falcão-Pires I; Vitorino R
J Proteomics; 2018 Jan; 171():37-52. PubMed ID: 28336332
[TBL] [Abstract][Full Text] [Related]
13. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers.
Suk K
Expert Rev Proteomics; 2010 Apr; 7(2):263-74. PubMed ID: 20377392
[TBL] [Abstract][Full Text] [Related]
15. Application of an Aptamer-Based Proteomics Assay (SOMAscan™) in Rat Cerebrospinal Fluid.
Simats A; Ramiro L; Montaner J; García-Berrocoso T
Methods Mol Biol; 2019; 2044():221-231. PubMed ID: 31432415
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers.
Hok-A-Hin YS; Willemse EAJ; Teunissen CE; Del Campo M
Methods Mol Biol; 2019; 2044():27-50. PubMed ID: 31432404
[TBL] [Abstract][Full Text] [Related]
17. Proteome Profiling of Sertoli Cells Using a GeLC-MS/MS Strategy.
Ferreira R; Trindade F; Vitorino R
Methods Mol Biol; 2018; 1748():173-190. PubMed ID: 29453572
[TBL] [Abstract][Full Text] [Related]
18. Preparation of human cerebrospinal fluid for proteomics biomarker analysis.
Waybright TJ
Methods Mol Biol; 2013; 1002():61-70. PubMed ID: 23625394
[TBL] [Abstract][Full Text] [Related]
19. CSF biomarkers in neurodegenerative and vascular dementias.
Llorens F; Schmitz M; Ferrer I; Zerr I
Prog Neurobiol; 2016; 138-140():36-53. PubMed ID: 27016008
[TBL] [Abstract][Full Text] [Related]
20. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
